Olsson Shawn
SEC CIK 2015796 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Chief Commercial Off | 14.7K | — | $261.0K | 4 | 2024-12-16 | 2025-11-17 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-19 | 2025-11-17 | LENZ | LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Off | M - OptEx | $2.08 | +10.0K | 14.7K | +211% | +$20.8K |
| DM | 2025-11-19 | 2025-11-17 | LENZ | LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Off | S - Sale+OE | $26.10 | -10.0K | 4,733 | -68% | -$261.0K |
| D | 2025-04-09 | 2025-04-09 | LENZ | LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Off | M - OptEx | $2.08 | +1,400 | 4,733 | +42% | +$2,912 |
| D | 2024-12-17 | 2024-12-16 | LENZ | LENZ Therapeutics, Inc. | Olsson Shawn | Chief Commercial Off | M - OptEx | $2.08 | +3,333 | 3,333 | New | +$6,933 |
Purchase Sale Sale after option exercise All abbreviations